SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-24-005222
Filing Date
2024-03-26
Accepted
2024-03-26 20:31:55
Documents
1
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-65375.html 4  
1 PRIMARY DOCUMENT marketforms-65375.xml 4 3311
  Complete submission text file 0001214659-24-005222.txt   4754
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 111 TENTH AVENUE SUITE 200 NASHVILLE TN 37203
Business Address
Galante Joseph C (Reporting) CIK: 0001632384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 24785480